1
|
Buzoianu-Anguiano V, Arriero-Cabañero A, Fernández-Mayoralas A, Torres-Llacsa M, Doncel-Pérez E. Axonal Growth and Fasciculation of Spinal Neurons Promoted by Aldynoglia in Alkaline Fibrin Hydrogel: Influence of Tol-51 Sulfoglycolipid. Int J Mol Sci 2024; 25:9173. [PMID: 39273121 PMCID: PMC11395328 DOI: 10.3390/ijms25179173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Revised: 08/13/2024] [Accepted: 08/20/2024] [Indexed: 09/15/2024] Open
Abstract
Traumatic spinal cord injury (tSCI) has complex pathophysiological events that begin after the initial trauma. One such event is fibroglial scar formation by fibroblasts and reactive astrocytes. A strong inhibition of axonal growth is caused by the activated astroglial cells as a component of fibroglial scarring through the production of inhibitory molecules, such as chondroitin sulfate proteoglycans or myelin-associated proteins. Here, we used neural precursor cells (aldynoglia) as promoters of axonal growth and a fibrin hydrogel gelled under alkaline conditions to support and guide neuronal cell growth, respectively. We added Tol-51 sulfoglycolipid as a synthetic inhibitor of astrocyte and microglia in order to test its effect on the axonal growth-promoting function of aldynoglia precursor cells. We obtained an increase in GFAP expression corresponding to the expected glial phenotype for aldynoglia cells cultured in alkaline fibrin. In co-cultures of dorsal root ganglia (DRG) and aldynoglia, the axonal growth promotion of DRG neurons by aldynoglia was not affected. We observed that the neural precursor cells first clustered together and then formed niches from which aldynoglia cells grew and connected to groups of adjacent cells. We conclude that the combination of alkaline fibrin with synthetic sulfoglycolipid Tol-51 increased cell adhesion, cell migration, fasciculation, and axonal growth capacity, promoted by aldynoglia cells. There was no negative effect on the behavior of aldynoglia cells after the addition of sulfoglycolipid Tol-51, suggesting that a combination of aldynoglia plus alkaline fibrin and Tol-51 compound could be useful as a therapeutic strategy for tSCI repair.
Collapse
Affiliation(s)
| | | | - Alfonso Fernández-Mayoralas
- Departamento de Química Bio-Orgánica, Instituto de Química Orgánica General (IQOG-CSIC), CSIC, 28006 Madrid, Spain
| | - Mabel Torres-Llacsa
- Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha, 45071 Toledo, Spain
| | - Ernesto Doncel-Pérez
- Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha, 45071 Toledo, Spain
| |
Collapse
|
2
|
Arriero-Cabañero A, García-Vences E, Sánchez-Torres S, Aristizabal-Hernandez S, García-Rama C, Pérez-Rizo E, Fernández-Mayoralas A, Grijalva I, Buzoianu-Anguiano V, Doncel-Pérez E, Mey J. Transplantation of Predegenerated Peripheral Nerves after Complete Spinal Cord Transection in Rats: Effect of Neural Precursor Cells and Pharmacological Treatment with the Sulfoglycolipid Tol-51. Cells 2024; 13:1324. [PMID: 39195214 DOI: 10.3390/cells13161324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Revised: 08/02/2024] [Accepted: 08/06/2024] [Indexed: 08/29/2024] Open
Abstract
Following spinal cord injury (SCI), the regenerative capacity of the central nervous system (CNS) is severely limited by the failure of axonal regeneration. The regeneration of CNS axons has been shown to occur by grafting predegenerated peripheral nerves (PPNs) and to be promoted by the transplantation of neural precursor cells (NPCs). The introduction of a combinatorial treatment of PPNs and NPCs after SCI has to address the additional problem of glial scar formation, which prevents regenerating axons from leaving the implant and making functional connections. Previously, we discovered that the synthetic sulfoglycolipid Tol-51 inhibits astrogliosis. The objective was to evaluate axonal regeneration and locomotor function improvement after SCI in rats treated with a combination of PPN, NPC, and Tol-51. One month after SCI, the scar tissue was removed and replaced with segments of PPN or PPN+Tol-51; PPN+NPC+Tol-51. The transplantation of a PPN segment favors regenerative axonal growth; in combination with Tol-51 and NPC, 30% of the labeled descending corticospinal axons were able to grow through the PPN and penetrate the caudal spinal cord. The animals treated with PPN showed significantly better motor function. Our data demonstrate that PPN implants plus NPC and Tol-51 allow successful axonal regeneration in the CNS.
Collapse
Affiliation(s)
| | - Elisa García-Vences
- Facultad de Ciencias de la Salud, Centro de Investigación en Ciencias de la Salud (CICSA), Universidad Anáhuac México Norte, Huixquilucan 52786, Mexico
- Secretaría de la Defensa Nacional, Escuela Militar de Graduados en Sanidad, Ciudad de Méxcio 11200, Mexico
| | - Stephanie Sánchez-Torres
- Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI. Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06720, Mexico
| | | | - Concepción García-Rama
- Laboratorio de Regeneración Neural, Hospital Nacional de Parapléjicos, 45071 Toledo, Spain
| | - Enrique Pérez-Rizo
- Unidad de Ingeniería y Evaluación Motora del Hospital Nacional de Parapléjicos, 45071 Toledo, Spain
| | | | - Israel Grijalva
- Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI. Av. Cuauhtémoc 330, Col. Doctores, Mexico City 06720, Mexico
| | | | - Ernesto Doncel-Pérez
- Laboratorio de Regeneración Neural, Hospital Nacional de Parapléjicos, 45071 Toledo, Spain
| | - Jörg Mey
- Laboratorio de Regeneración Neural, Hospital Nacional de Parapléjicos, 45071 Toledo, Spain
- EURON Graduate School of Neuroscience, 6229ER Maastricht, The Netherlands
| |
Collapse
|
3
|
Aguilar-Guadarrama AB, Díaz-Román MA, Osorio-García M, Déciga-Campos M, Rios MY. Chemical Constituents from Agave applanata and Its Antihyperglycemic, Anti-inflammatory, and Antimicrobial Activities Associated with Its Tissue Repair Capability. PLANTA MEDICA 2024; 90:397-410. [PMID: 38365219 DOI: 10.1055/a-2270-5527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/18/2024]
Abstract
Agave applanata is a Mexican agave whose fresh leaves are employed to prepare an ethanol tonic used to relieve diabetes. It is also applied to skin to relieve varicose and diabetic foot ulcers, including wounds, inflammation, and infections. In this study, the chemical composition of this ethanol tonic is established and its association with antihyperglycemic, anti-inflammatory, antimicrobial, and wound healing activities is discussed. The fresh leaves of A. applanata were extracted with ethanol : H2O (85 : 15). A fraction of this extract was lyophilized, and the remainder was partitioned into CH2Cl2, n-BuOH, and water. CH2Cl2 and n-BuOH fractions were subjected to a successive open column chromatography process. The structure of the isolated compounds was established using nuclear magnetic resonance and mass spectrometry spectra. The antihyperglycemic activity was evaluated through in vivo sucrose and glucose tolerance experiments, as well as ex vivo intestinal absorption and hepatic production of glucose. Wound healing and edema inhibition were assayed in mice. The minimum inhibitory concentrations (MICs) of the hydroalcoholic extract, its fractions, and pure compounds were determined through agar microdilution against the most isolated pathogens from diabetic foot ulcers. Fatty acids, β-sitosterol, stigmasterol, hecogenin (1: ), N-oleyl-D-glucosamine, β-daucosterol, sucrose, myo-inositol, and hecogenin-3-O-α-L-rhamnopyranosyl-(1 → 3)-β-D-xylopyranosyl-(1 → 2)-[β-D-xylopyranosyl-(1 → 3)-β-D-glucopyranosyl-(1 → 3)]-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (2: ) were characterized. This research provides evidence for the pharmacological importance of A. applanata in maintaining normoglycemia, showing anti-inflammatory activity and antimicrobial effects against the microorganisms frequently found in diabetic foot ulcers. This plant plays an important role in wound healing and accelerated tissue reparation.
Collapse
Affiliation(s)
| | - Mónica Aideé Díaz-Román
- Centro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Morelos, México
| | - Maribel Osorio-García
- Centro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Morelos, México
| | - Myrna Déciga-Campos
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México
| | - María Yolanda Rios
- Centro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Morelos, México
| |
Collapse
|
4
|
Porter J, Parisi D, Miller T, Cheallaigh AN, Miller GJ. Chemical synthesis of amphiphilic glycoconjugates: Access to amino, fluorinated and sulfhydryl oleyl glucosides. Carbohydr Res 2023; 530:108854. [PMID: 37329646 DOI: 10.1016/j.carres.2023.108854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 05/23/2023] [Accepted: 05/23/2023] [Indexed: 06/19/2023]
Abstract
Amphiphilic glycoconjugates offer an important prospect for development as chemical biology tools and biosurfactants. The chemical synthesis of such materials is required to expedite such prospect, compounded by the example of oleyl glycosides. Herein, we report a mild and reliable glycosylation method to access oleyl glucosides, glycosidating oleyl alcohol with α-trichloroacetimidate donors. We demonstrate capability for this methodology, extending it to synthesise the first examples of pyranose-component fluorination and sulfhydryl modifications within glucosides and glucosamines of oleyl alcohol. These compounds provide an exciting series of tools to explore processes and materials that utilise oleyl glycosides, including as probes for glycosphingolipid metabolism.
Collapse
Affiliation(s)
- Jack Porter
- Centre for Glycoscience, Keele University, Keele, Staffordshire, ST5 5BG, UK; Lennard-Jones Laboratory, School of Chemical and Physical Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK
| | - Daniele Parisi
- Croda Europe Ltd., Oak Road, Clough Road, Hull, HU6 7PH, UK
| | - Timothy Miller
- Croda Europe Ltd., Oak Road, Clough Road, Hull, HU6 7PH, UK
| | - Aisling Ní Cheallaigh
- Centre for Glycoscience, Keele University, Keele, Staffordshire, ST5 5BG, UK; Lennard-Jones Laboratory, School of Chemical and Physical Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK
| | - Gavin J Miller
- Centre for Glycoscience, Keele University, Keele, Staffordshire, ST5 5BG, UK; Lennard-Jones Laboratory, School of Chemical and Physical Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK.
| |
Collapse
|
5
|
Laborda P, Lyu Y, Parmeggiani F, Lu A, Wang W, Huang Y, Huang K, Guo J, Liu L, Flitsch SL, Voglmeir J. An Enzymatic N‐Acylation Step Enables the Biocatalytic Synthesis of Unnatural Sialosides. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.201914338] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Pedro Laborda
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
- Current address: School of Life SciencesNantong University 19 Qixiu Road 226019 Nantong China
| | - Yong‐Mei Lyu
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
| | - Fabio Parmeggiani
- School of Chemistry & Manchester Institute of BiotechnologyThe University of Manchester 131 Princess Street M1 7DN Manchester UK
| | - Ai‐Min Lu
- College of SciencesNanjing Agricultural University 1 Weigang 210095 Nanjing China
| | - Wen‐Jiao Wang
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
| | - Ying‐Ying Huang
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
| | - Kun Huang
- School of Chemistry & Manchester Institute of BiotechnologyThe University of Manchester 131 Princess Street M1 7DN Manchester UK
| | - Juan Guo
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
| | - Li Liu
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
| | - Sabine L. Flitsch
- School of Chemistry & Manchester Institute of BiotechnologyThe University of Manchester 131 Princess Street M1 7DN Manchester UK
| | - Josef Voglmeir
- Glycomics and Glycan Bioengineering Research Center (GGBRC)College of Food Science and TechnologyNanjing Agricultural University 1 Weigang 210095 Nanjing China
| |
Collapse
|
6
|
Laborda P, Lyu YM, Parmeggiani F, Lu AM, Wang WJ, Huang YY, Huang K, Guo J, Liu L, Flitsch SL, Voglmeir J. An Enzymatic N-Acylation Step Enables the Biocatalytic Synthesis of Unnatural Sialosides. Angew Chem Int Ed Engl 2020; 59:5308-5311. [PMID: 31834658 DOI: 10.1002/anie.201914338] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2019] [Revised: 12/10/2019] [Indexed: 12/22/2022]
Abstract
Chitin is one of the most abundant and cheaply available biopolymers in Nature. Chitin has become a valuable starting material for many biotechnological products through manipulation of its N-acetyl functionality, which can be cleaved under mild conditions using the enzyme family of de-N-acetylases. However, the chemoselective enzymatic re-acylation of glucosamine derivatives, which can introduce new stable functionalities into chitin derivatives, is much less explored. Herein we describe an acylase (CmCDA from Cyclobacterium marinum) that catalyzes the N-acylation of glycosamine with a range of carboxylic acids under physiological reaction conditions. This biocatalyst closes an important gap in allowing the conversion of chitin into complex glycosides, such as C5-modified sialosides, through the use of highly selective enzyme cascades.
Collapse
Affiliation(s)
- Pedro Laborda
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China.,Current address: School of Life Sciences, Nantong University, 19 Qixiu Road, 226019, Nantong, China
| | - Yong-Mei Lyu
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| | - Fabio Parmeggiani
- School of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, M1 7DN, Manchester, UK
| | - Ai-Min Lu
- College of Sciences, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| | - Wen-Jiao Wang
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| | - Ying-Ying Huang
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| | - Kun Huang
- School of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, M1 7DN, Manchester, UK
| | - Juan Guo
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| | - Li Liu
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| | - Sabine L Flitsch
- School of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, M1 7DN, Manchester, UK
| | - Josef Voglmeir
- Glycomics and Glycan Bioengineering Research Center (GGBRC), College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, 210095, Nanjing, China
| |
Collapse
|
7
|
Glyco-nanoparticles: New drug delivery systems in cancer therapy. Semin Cancer Biol 2019; 69:24-42. [PMID: 31870939 DOI: 10.1016/j.semcancer.2019.12.004] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 11/28/2019] [Accepted: 12/02/2019] [Indexed: 12/24/2022]
Abstract
Cancer is known as one of the most common diseases that are associated with high mobility and mortality in the world. Despite several efforts, current cancer treatment modalities often are highly toxic and lack efficacy and specificity. However, the application of nanotechnology has led to the development of effective nanosized drug delivery systems which are highly selective for tumors and allow a slow release of active anticancer agents. Different Nanoparticles (NPs) such as the silicon-based nano-materials, polymers, liposomes and metal NPs have been designed to deliver anti-cancer drugs to tumor sites. Among different drug delivery systems, carbohydrate-functionalized nanomaterials, specially based on their multi-valent binding capacities and desirable bio-compatibility, have attracted considerable attention as an excellent candidate for controlled release of therapeutic agents. In addition, these carbohydrate functionalized nano-carriers are more compatible with construction of the intracellular delivery platforms like the carbohydrate-modified metal NPs, quantum dots, and magnetic nano-materials. In this review, we discuss recent research in the field of multifunctional glycol-nanoparticles (GNPs) intended for cancer drug delivery applications.
Collapse
|
8
|
Carvalho LCR, Queda F, Almeida CV, Filipe SR, Marques MMB. From a Natural Polymer to Relevant NAG‐NAM Precursors. ASIAN J ORG CHEM 2018. [DOI: 10.1002/ajoc.201800592] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Luísa C. R. Carvalho
- LAQV@REQUIMTE, Departamento de Química, Faculdade de Ciências e TecnologiaUniversidade Nova de Lisboa Campus de Caparica 2829-516 Caparica Portugal
| | - Fausto Queda
- LAQV@REQUIMTE, Departamento de Química, Faculdade de Ciências e TecnologiaUniversidade Nova de Lisboa Campus de Caparica 2829-516 Caparica Portugal
| | - Cátia V. Almeida
- LAQV@REQUIMTE, Departamento de Química, Faculdade de Ciências e TecnologiaUniversidade Nova de Lisboa Campus de Caparica 2829-516 Caparica Portugal
| | - Sérgio R. Filipe
- UCIBIO@REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e TecnologiaUniversidade Nova de Lisboa Campus de Caparica 2829-516 Caparica Portugal
- Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e BiológicaUniversidade Nova de Lisboa 2780-157 Oeiras Portugal
| | - M. Manuel B. Marques
- LAQV@REQUIMTE, Departamento de Química, Faculdade de Ciências e TecnologiaUniversidade Nova de Lisboa Campus de Caparica 2829-516 Caparica Portugal
| |
Collapse
|
9
|
Micellar Iron Oxide Nanoparticles Coated with Anti-Tumor Glycosides. NANOMATERIALS 2018; 8:nano8080567. [PMID: 30044386 PMCID: PMC6116232 DOI: 10.3390/nano8080567] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Revised: 07/22/2018] [Accepted: 07/23/2018] [Indexed: 01/02/2023]
Abstract
The synthesis procedure of nanoparticles based on thermal degradation produces organic solvent dispersible iron oxide nanoparticles (OA-IONP) with oleic acid coating and unique physicochemical properties of the core. Some glycosides with hydrophilic sugar moieties bound to oleyl hydrophobic chains have antimitotic activity on cancer cells but reduced in vivo applications because of the intrinsic low solubility in physiological media, and are prone to enzymatic hydrolysis. In this manuscript, we have synthetized and characterized OA-IONP-based micelles encapsulated within amphiphilic bioactive glycosides. The glycoside-coated IONP micelles were tested as Magnetic Resonance Imaging (MRI) contrast agents as well as antimitotics on rat glioma (C6) and human lung carcinoma (A549) cell lines. Micelle antimitotic activity was compared with the activity of the corresponding free glycosides. In general, all OA-IONP-based micellar formulations of these glycosides maintained their anti-tumor effects, and, in one case, showed an unusual therapeutic improvement. Finally, the micelles presented optimal relaxometric properties for their use as T2-weighed MRI contrast agents. Our results suggest that these bioactive hydrophilic nano-formulations are theranostic agents with synergistic properties obtained from two entities, which separately are not ready for in vivo applications, and strengthen the possibility of using biomolecules as both a coating for OA-IONP micellar stabilization and as drugs for therapy.
Collapse
|
10
|
Govindarajan M. Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics. Eur J Med Chem 2017; 143:1208-1253. [PMID: 29126728 DOI: 10.1016/j.ejmech.2017.10.015] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2017] [Revised: 09/14/2017] [Accepted: 10/08/2017] [Indexed: 12/13/2022]
Abstract
Amphiphilicity is one of the desirable features in the process of drug development which improves the biological as well as the pharmacokinetics profile of bioactive molecule. Carbohydrate moieties present in anti-cancer natural products and synthetic molecules influence the amphiphilicity and hence their bioactivity. This review focuses on natural and synthetic amphiphilic anti-cancer glycoconjugates. Different classes of molecules with varying degree of amphiphilicity are covered with discussions on their structure-activity relationship and mechanism of action.
Collapse
Affiliation(s)
- Mugunthan Govindarajan
- Emory Institute for Drug Development, Emory University, 954 Gatewood Road, Atlanta, GA 30329, United States.
| |
Collapse
|
11
|
Maiti B, Haldar U, Rajasekhar T, De P. Functional-Polymer Library through Post-Polymerization Modification of Copolymers Having Oleate and Pentafluorophenyl Pendants. Chemistry 2017; 23:15156-15165. [PMID: 28850744 DOI: 10.1002/chem.201703151] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Indexed: 01/11/2023]
Affiliation(s)
- Binoy Maiti
- Department of Chemical Sciences; Indian Institute of Science Education and Research Kolkata; Mohanpur Nadia, West Bengal 741246 India
| | - Ujjal Haldar
- Department of Chemical Sciences; Indian Institute of Science Education and Research Kolkata; Mohanpur Nadia, West Bengal 741246 India
| | - Tota Rajasekhar
- Department of Chemical Sciences; Indian Institute of Science Education and Research Kolkata; Mohanpur Nadia, West Bengal 741246 India
| | - Priyadarsi De
- Department of Chemical Sciences; Indian Institute of Science Education and Research Kolkata; Mohanpur Nadia, West Bengal 741246 India
| |
Collapse
|
12
|
Ji S, Shen W, Chen L, Zhang Y, Wu X. Synthesis and properties of alkoxyethyl 2-acetamido-2-deoxy- α - D -glucopyranoside. J Mol Liq 2017. [DOI: 10.1016/j.molliq.2017.08.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
|
13
|
Kaebisch E, Fuss TL, Vandergrift L, Toews K, Habbel P, Cheng LL. Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models. NMR IN BIOMEDICINE 2017; 30:10.1002/nbm.3700. [PMID: 28301071 PMCID: PMC5501085 DOI: 10.1002/nbm.3700] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2016] [Revised: 10/04/2016] [Accepted: 12/31/2016] [Indexed: 05/09/2023]
Abstract
High-resolution magic angle spinning (HRMAS) MRS allows for direct measurements of non-liquid tissue and cell specimens to present valuable insights into the cellular metabolisms of physiological and pathological processes. HRMAS produces high-resolution spectra comparable to those obtained from solutions of specimen extracts but without complex metabolite extraction processes, and preserves the tissue cellular structure in a form suitable for pathological examinations following spectroscopic analysis. The technique has been applied in a wide variety of biomedical and biochemical studies and become one of the major platforms of metabolomic studies. By quantifying single metabolites, metabolite ratios, or metabolic profiles in their entirety, HRMAS presents promising possibilities for diagnosis and prediction of clinical outcomes for various diseases, as well as deciphering of metabolic changes resulting from drug therapies or xenobiotic interactions. In this review, we evaluate HRMAS MRS results on animal models and cell lines reported in the literature, and present the diverse applications of the method for the understanding of pathological processes and the effectiveness of therapies, development of disease animal models, and new progress in HRMAS methodology.
Collapse
Affiliation(s)
- Eva Kaebisch
- Departments of Radiology and Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, 02114 USA
- Department of Hematology and Oncology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - Taylor L. Fuss
- Departments of Radiology and Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, 02114 USA
| | - Lindsey Vandergrift
- Departments of Radiology and Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, 02114 USA
| | - Karin Toews
- Departments of Radiology and Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, 02114 USA
- Department of Hematology and Oncology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - Piet Habbel
- Department of Hematology and Oncology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
| | - Leo L. Cheng
- Departments of Radiology and Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, 02114 USA
- Corresponding Author: Leo L. Cheng, PhD, 149 13 Street, CNY-6, Charlestown, MA 02129, Ph.617-724-6593, Fax.617-726-5684,
| |
Collapse
|
14
|
Punzón E, García-Alvarado F, Maroto M, Fernández-Mendívil C, Michalska P, García-Álvarez I, Arranz-Tagarro JA, Buendia I, López MG, León R, Gandía L, Fernández-Mayoralas A, García AG. Novel sulfoglycolipid IG20 causes neuroprotection by activating the phase II antioxidant response in rat hippocampal slices. Neuropharmacology 2016; 116:110-121. [PMID: 28007500 DOI: 10.1016/j.neuropharm.2016.12.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2016] [Revised: 10/31/2016] [Accepted: 12/18/2016] [Indexed: 10/20/2022]
Abstract
Compound IG20 is a newly synthesised sulphated glycolipid that promotes neuritic outgrowth and myelinisation, at the time it causes the inhibition of glial proliferation and facilitates exocytosis in chromaffin cells. Here we have shown that IG20 at 0.3-10 μM afforded neuroprotection in rat hippocampal slices stressed with veratridine, glutamate or with oxygen plus glucose deprivation followed by reoxygenation (OGD/reox). Excess production of reactive oxygen species (ROS) elicited by glutamate or ODG/reox was prevented by IG20 that also restored the depressed tissue levels of GSH and ATP in hippocampal slices subjected to OGD/reox. Furthermore, the augmented iNOS expression produced upon OGD/reox exposure was also counteracted by IG20. Additionally, the IG20 elicited neuroprotection was prevented by the presence of inhibitors of the signalling pathways Jak2/STAT3, MEK/ERK1/2, and PI3K/Akt, consistent with the ability of the compound to increase the phosphorylation of Jak2, ERK1/2, and Akt. Thus, the activation of phase II response and the Nrf2/ARE pathway could explain the antioxidant and anti-inflammatory effects and the ensuing neuroprotective actions of IG20.
Collapse
Affiliation(s)
- Eva Punzón
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Fernanda García-Alvarado
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Marcos Maroto
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Cristina Fernández-Mendívil
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Patrycja Michalska
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Isabel García-Álvarez
- Hospital Nacional de Parapléjicos, SESCAM, Finca La Peraleda s/n, 45071 Toledo, Spain
| | - Juan Alberto Arranz-Tagarro
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Izaskun Buendia
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Manuela G López
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | - Rafael León
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, c/ Diego de León, 62, 28006 Madrid, Spain
| | - Luis Gandía
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain
| | | | - Antonio G García
- Instituto Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/ Arzobispo Morcillo, 4, 28029 Madrid, Spain; Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, c/ Diego de León, 62, 28006 Madrid, Spain.
| |
Collapse
|
15
|
García-Álvarez I, Fernández-Mayoralas A, Moreno-Lillo S, Sánchez-Sierra M, Nieto-Sampedro M, Doncel-Pérez E. Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment. Restor Neurol Neurosci 2016; 33:895-910. [PMID: 26484699 DOI: 10.3233/rnn-150572] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
PURPOSE After spinal cord injury (SCI) a glial scar is generated in the area affected that forms a barrier for axon growth and myelination, preventing functional recovery. Recently, we have described a synthetic glycolipid (IG20) that inhibited proliferation of human glioma cells. We show now that IG20 inhibited the proliferation of astrocytes and microglial cells, the principal cellular components of the glial scar, and promoting axonal outgrowth and myelin production in vitro. METHODS Glial cells were inhibited with IG20 (IC50≈10 μM) and studied by RT-PCR, Western Blotting, immunoprecipitation and fluorescence microscopy. Axonal outgrowth in dorsal root ganglia (DRG) and myelin production by oligodendrocytes were analyzed by immunocytochemistry. Adult rats were assayed in spinal cord contusion model and the recovery of treated animals (n = 6) and controls (n = 6) was followed. RESULTS The IG20 was localized in the cytosol of glial cells, forming a complex with RhoGDIα, a regulator of RhoGTPases. Treatment of astroglial cultures with IG20 increase the expression of BDNF receptor genes (TrkBT1, TrkB Full). IG20 reduced the astroglial marker GFAP, while increasing production of myelin basic protein in oligodendrocytes and promoted axonal outgrowth from DRG neurons. Local injection of IG20, near a spinal cord contusion, promoted the recovery of lesioned animals analyzed by BBB test (P < 0.05). CONCLUSIONS We propose that inhibition of astrocytes and microglia by IG20 could be diminished the glial scar formation, inducing the re-growth and myelination of axons, these elements constitute a new approach for SCI therapy.
Collapse
Affiliation(s)
- Isabel García-Álvarez
- Grupo de Química Neuro-regenerativa, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha (SESCAM), Finca La Peraleda s/n, Toledo, Spain
| | | | - Sandra Moreno-Lillo
- Grupo de Química Neuro-regenerativa, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha (SESCAM), Finca La Peraleda s/n, Toledo, Spain
| | - María Sánchez-Sierra
- Grupo de Química Neuro-regenerativa, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha (SESCAM), Finca La Peraleda s/n, Toledo, Spain
| | | | - Ernesto Doncel-Pérez
- Grupo de Química Neuro-regenerativa, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla La Mancha (SESCAM), Finca La Peraleda s/n, Toledo, Spain
| |
Collapse
|
16
|
Crespo-Castrillo A, Punzón E, de Pascual R, Maroto M, Padín JF, García-Álvarez I, Nanclares C, Ruiz-Pascual L, Gandía L, Fernández-Mayoralas A, García AG. Novel synthetic sulfoglycolipid IG20 facilitates exocytosis in chromaffin cells through the regulation of sodium channels. J Neurochem 2015; 135:880-96. [DOI: 10.1111/jnc.13357] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2015] [Revised: 08/03/2015] [Accepted: 08/19/2015] [Indexed: 11/27/2022]
Affiliation(s)
- Andrea Crespo-Castrillo
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | - Eva Punzón
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | - Ricardo de Pascual
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
- Departamento de Farmacología; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | - Marcos Maroto
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | - Juan Fernando Padín
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
- Departamento de Farmacología; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | | | - Carmen Nanclares
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
- Departamento de Farmacología; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | - Lucía Ruiz-Pascual
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | - Luis Gandía
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
- Departamento de Farmacología; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
| | | | - Antonio G. García
- Instituto Teófilo Hernando; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
- Departamento de Farmacología; Facultad de Medicina; Universidad Autónoma de Madrid; Madrid Spain
- Servicio de Farmacología Clínica; Instituto de Investigación Sanitaria; Hospital Universitario de La Princesa; Madrid Spain
| |
Collapse
|
17
|
Romero-Ramírez L, García-Álvarez I, Casas J, Barreda-Manso M, Yanguas-Casás N, Nieto-Sampedro M, Fernández-Mayoralas A. New oleyl glycoside as anti-cancer agent that targets on neutral sphingomyelinase. Biochem Pharmacol 2015. [DOI: 10.1016/j.bcp.2015.07.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
18
|
Mass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury Treatment. BIOMED RESEARCH INTERNATIONAL 2015; 2015:169234. [PMID: 26090386 PMCID: PMC4452236 DOI: 10.1155/2015/169234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/25/2014] [Revised: 09/16/2014] [Accepted: 09/16/2014] [Indexed: 11/19/2022]
Abstract
The studies of drugs that could constitute a palliative to spinal cord injury (SCI) are a continuous and increasing demand in biomedicine field from developed societies. Recently we described the chemical synthesis and antiglioma activity of synthetic glycosides. A synthetic sulfated glycolipid (here IG20) has shown chemical stability, solubility in polar solvents, and high inhibitory capacity over glioma growth. We have used mass spectrometry (MS) to monitor IG20 (m/z = 550.3) in cells and tissues of the central nervous system (CNS) that are involved in SCI recovery. IG20 was detected by MS in serum and homogenates from CNS tissue of rats, though in the latter a previous deproteinization step was required. The pharmacokinetic parameters of serum clearance at 24 h and half-life at 4 h were determined for synthetic glycoside in the adult rat using MS. A local administration of the drug near of spinal lesion site is proposed.
Collapse
|
19
|
García-Álvarez I, Garrido L, Romero-Ramírez L, Nieto-Sampedro M, Fernández-Mayoralas A, Campos-Olivas R. The effect of antitumor glycosides on glioma cells and tissues as studied by proton HR-MAS NMR spectroscopy. PLoS One 2013; 8:e78391. [PMID: 24194925 PMCID: PMC3806797 DOI: 10.1371/journal.pone.0078391] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2013] [Accepted: 09/20/2013] [Indexed: 12/21/2022] Open
Abstract
The effect of the treatment with glycolipid derivatives on the metabolic profile of intact glioma cells and tumor tissues, investigated using proton high resolution magic angle spinning (1H HR-MAS) nuclear magnetic resonance (NMR) spectroscopy, is reported here. Two compounds were used, a glycoside and its thioglycoside analogue, both showing anti-proliferative activity on glioma C6 cell cultures; however, only the thioglycoside exhibited antitumor activity in vivo. At the drug concentrations showing anti-proliferative activity in cell culture (20 and 40 µM), significant increases in choline containing metabolites were observed in the 1H NMR spectra of the same intact cells. In vivo experiments in nude mice bearing tumors derived from implanted C6 glioma cells, showed that reduction of tumor volume was associated with significant changes in the metabolic profile of the same intact tumor tissues; and were similar to those observed in cell culture. Specifically, the activity of the compounds is mainly associated with an increase in choline and phosphocholine, in both the cell cultures and tumoral tissues. Taurine, a metabolite that has been considered a biomarker of apoptosis, correlated with the reduction of tumor volume. Thus, the results indicate that the mode of action of the glycoside involves, at least in part, alteration of phospholipid metabolism, resulting in cell death.
Collapse
Affiliation(s)
- Isabel García-Álvarez
- Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
- Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
- * E-mail: (IG-A); (RC-O)
| | - Leoncio Garrido
- Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Lorenzo Romero-Ramírez
- Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
- Instituto Cajal de Neurobiología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Manuel Nieto-Sampedro
- Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
- Instituto Cajal de Neurobiología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Alfonso Fernández-Mayoralas
- Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Ramón Campos-Olivas
- Spectroscopy and NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Center (CNIO), Madrid, Spain
- * E-mail: (IG-A); (RC-O)
| |
Collapse
|
20
|
Doncel-Pérez E, García-Álvarez I, Fernández-Mayoralas A, Nieto-Sampedro M. Synthetic glycolipids for glioma growth inhibition developed from neurostatin and NF115 compound. Bioorg Med Chem Lett 2013; 23:435-9. [DOI: 10.1016/j.bmcl.2012.11.070] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2012] [Revised: 11/17/2012] [Accepted: 11/18/2012] [Indexed: 10/27/2022]
|
21
|
López-Donaire ML, Sussman EM, Fernández-Gutiérrez M, Méndez-Vilas A, Ratner BD, Vázquez-Lasa B, San Román J. Amphiphilic Self-Assembled “Polymeric Drugs”: Morphology, Properties, and Biological Behavior of Nanoparticles. Biomacromolecules 2012; 13:624-35. [DOI: 10.1021/bm300043f] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- María Luisa López-Donaire
- Institute of Polymer Science and Technology, CSIC, C/Juan de la Cierva 3,
28006 Madrid, Spain
- CIBER-BBN, Ebro River Campus, Building R&D, Block 5, Floor 1, Poeta Mariano Esquillor s/n, 50017 Zaragoza, Spain
| | - Eric M. Sussman
- Department of Bioengineering, University of Washington, Seattle, Washington
98195-5061, United States
| | - Mar Fernández-Gutiérrez
- Institute of Polymer Science and Technology, CSIC, C/Juan de la Cierva 3,
28006 Madrid, Spain
- CIBER-BBN, Ebro River Campus, Building R&D, Block 5, Floor 1, Poeta Mariano Esquillor s/n, 50017 Zaragoza, Spain
| | - Antonio Méndez-Vilas
- CIBER-BBN, Ebro River Campus, Building R&D, Block 5, Floor 1, Poeta Mariano Esquillor s/n, 50017 Zaragoza, Spain
| | - Buddy D. Ratner
- Department of Bioengineering, University of Washington, Seattle, Washington
98195-5061, United States
| | - Blanca Vázquez-Lasa
- Institute of Polymer Science and Technology, CSIC, C/Juan de la Cierva 3,
28006 Madrid, Spain
- CIBER-BBN, Ebro River Campus, Building R&D, Block 5, Floor 1, Poeta Mariano Esquillor s/n, 50017 Zaragoza, Spain
| | - Julio San Román
- Institute of Polymer Science and Technology, CSIC, C/Juan de la Cierva 3,
28006 Madrid, Spain
- CIBER-BBN, Ebro River Campus, Building R&D, Block 5, Floor 1, Poeta Mariano Esquillor s/n, 50017 Zaragoza, Spain
| |
Collapse
|
22
|
Nieto-Sampedro M, Valle-Argos B, Gómez-Nicola D, Fernández-Mayoralas A, Nieto-Díaz M. Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. Clin Med Insights Oncol 2011; 5:265-314. [PMID: 22084619 PMCID: PMC3201112 DOI: 10.4137/cmo.s7685] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Treated glioblastoma patients survive from 6 to 14 months. In the first part of this review, we describe glioma origins, cancer stem cells and the genomic alterations that generate dysregulated cell division, with enhanced proliferation and diverse response to radiation and chemotherapy. We review the pathways that mediate tumour cell proliferation, neo-angiogenesis, tumor cell invasion, as well as necrotic and apoptotic cell death. Then, we examine the ability of gliomas to evade and suppress the host immune system, exhibited at the levels of antigen recognition and immune activation, limiting the effective signaling between glioma and host immune cells.The second part of the review presents current therapies and their drawbacks. This is followed by a summary of the work of our laboratory during the past 20 years, on oligosaccharide and glycosphingolipid inhibitors of astroblast and astrocytoma division. Neurostatins, the O-acetylated forms of gangliosides GD1b and GT1b naturally present in mammalian brain, are cytostatic for normal astroblasts, but cytotoxic for rat C6 glioma cells and human astrocytoma grades III and IV, with ID50 values ranging from 200 to 450 nM. The inhibitors do not affect neurons or fibroblasts up to concentrations of 4 μM or higher.At least four different neurostatin-activated, cell-mediated antitumoral processes, lead to tumor destruction: (i) inhibition of tumor neovascularization; (ii) activation of microglia; (iii) activation of natural killer (NK) cells; (iv) activation of cytotoxic lymphocytes (CTL). The enhanced antigenicity of neurostatin-treated glioma cells, could be related to their increased expression of connexin 43. Because neurostatins and their analogues show specific activity and no toxicity for normal cells, a clinical trial would be the logical next step.
Collapse
Affiliation(s)
- Manuel Nieto-Sampedro
- Instituto Cajal de Neurobiología, CSIC, 28002 Madrid, Spain
- Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain
| | - Beatriz Valle-Argos
- Instituto Cajal de Neurobiología, CSIC, 28002 Madrid, Spain
- Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain
| | - Diego Gómez-Nicola
- Instituto Cajal de Neurobiología, CSIC, 28002 Madrid, Spain
- Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain
| | | | | |
Collapse
|
23
|
García-Álvarez I, Groult H, Casas J, Barreda-Manso MA, Yanguas-Casás N, Nieto-Sampedro M, Romero-Ramírez L, Fernández-Mayoralas A. Synthesis of Antimitotic Thioglycosides: In Vitro and in Vivo Evaluation of Their Anticancer Activity. J Med Chem 2011; 54:6949-55. [DOI: 10.1021/jm200961q] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Isabel García-Álvarez
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
| | - Hugo Groult
- Instituto de Química Orgánica General, CSIC, Juan de la Cierva, 3, 28006 Madrid, Spain
| | - Josefina Casas
- RUBAM Institut de Química Avançada de Catalunya, CSIC, Jordi Girona, 18, 08034 Barcelona, Spain
| | - M. Asunción Barreda-Manso
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | - Natalia Yanguas-Casás
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | - Manuel Nieto-Sampedro
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | - Lorenzo Romero-Ramírez
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | | |
Collapse
|
24
|
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. Bioorg Med Chem 2011; 19:7720-7. [PMID: 22079865 DOI: 10.1016/j.bmc.2011.07.053] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2011] [Revised: 07/21/2011] [Accepted: 07/23/2011] [Indexed: 11/24/2022]
Abstract
New derivatives of 1,4-dideoxy-1,4-imino-D-ribitol have been prepared and evaluated for their cytotoxicity on solid and haematological malignancies. 1,4-Dideoxy-5-O-[(9Z)-octadec-9-en-1-yl]-1,4-imino-D-ribitol (13, IC(50) ∼2 μM) and its C(18)-analogues (IC(50) <10 μM) are cytotoxic toward SKBR3 (breast cancer) cells. 13 also inhibits (IC(50) ∼8 μM) growth of JURKAT cells.
Collapse
|
25
|
García-Álvarez I, Egido-Gabás M, Romero-Ramírez L, Doncel-Pérez E, Nieto-Sampedro M, Casas J, Fernández-Mayoralas A. Lipid and ganglioside alterations in tumor cells treated with antimitotic oleyl glycoside. MOLECULAR BIOSYSTEMS 2010; 7:129-38. [PMID: 21057675 DOI: 10.1039/c0mb00125b] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Oleyl 2-acetamido-2-deoxy-α-D-glucopyranoside (1) was previously shown to exhibit antimitotic activity on glioma (C6) and melanoma (A375) cell lines. Preliminary studies about its mechanism of action using (1)H MAS NMR suggested that 1 may be altering the metabolism of lipids. We have now studied the effect of 1 on the fatty acid, sphingolipid and ganglioside content in a line of carcinomic human alveolar epithelial cells (A549) using UPLC-MS. Oleic acid and NB-DNJ were used as positive controls for inhibition of fatty acid and ganglioside synthesis, respectively. Compound 1 (10 μM) was more efficient than oleic acid in reducing fatty acid levels of A549 cells, producing a decrease in the range of 40-15%, depending on the acyl chain length and the number of insaturations. In addition, glycoside 1 caused a reduction on ganglioside content of A549 tumor cell line and accumulation of lactosylceramide, the common metabolic precursor for ganglioside biosynthesis. Alteration of ganglioside metabolism was also observed with two galactosylated derivatives of 1, which caused a more pronounced increase in lactosylceramide levels. Compound 1 at higher concentrations (above 30 μM) produced drastic alterations in glycosphingolipid metabolism, leading to cell metabolic profiles very different from those obtained at 10 μM. These biochemical changes were ascribed to activation of endoplasmic reticulum stress pathways.
Collapse
|
26
|
López-Donaire ML, Parra-Cáceres J, Fernández-Gutiérrez M, Vázquez-Lasa B, Román JS. Polymeric drugs based on random copolymers with antimitotic activity. Biomacromolecules 2010; 11:2478-86. [PMID: 20695637 DOI: 10.1021/bm100672c] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Polymeric drugs based on random copolymers with antimitotic activity were obtained by free radical copolymerization of oleyl 2-acetamido-2-deoxy-α-d-glucopyranoside methacrylate (OAGMA) and 2-ethyl-(2-pyrrolidone) methacrylate (EPM) at low and high conversion and analyzed in terms of microstructure, physicochemical, and biological properties. Reactivity ratios of monomers were found to be r(OAGMA) = 1.34 and r(EPM) = 0.98, indicating the obtaining of statistical copolymers with random sequence distribution of the comonomeric units in the macromolecular chains. The glass transition temperature of the copolymers presents a negative deviation from the predicted values according to the Fox equation, suggesting a higher flexibility of the alternating diad. Copolymeric systems with OAGMA contents between 10-50 mol % presented thermosensitive behavior in a heating process showing cloud point temperatures (CPT) in the range 45-28 °C with increasing OAGMA content and hysteresis in one heating-and-cooling cycle. In vitro glycolipid release studies revealed the stability of the ester group in culture medium. The polymeric drugs with 30 and 50 mol % OAGMA presented antimitotic activity on a human glioblastoma line, but they were less toxic on normal human fibroblast cultures.
Collapse
Affiliation(s)
- M L López-Donaire
- Institute of Polymer Science and Technology, CSIC, Juan de la Cierva, 3, 28006 Madrid, Spain
| | | | | | | | | |
Collapse
|
27
|
Borcard F, Baud M, Bello C, Dal Bello G, Grossi F, Pronzato P, Cea M, Nencioni A, Vogel P. Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity. Bioorg Med Chem Lett 2010; 20:5353-6. [DOI: 10.1016/j.bmcl.2009.09.019] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2009] [Revised: 09/03/2009] [Accepted: 09/04/2009] [Indexed: 11/15/2022]
|
28
|
Tabassum S, Khan RA, Arjmand F, Juvekar AS, Zingde SM. Synthesis of carbohydrate-conjugate heterobimetallic Cu(II)-Sn(2)(IV) and Zn(II)-Sn(2)(IV) complexes; their interactions with CT DNA and nucleotides; DNA cleavage, in-vitro cytotoxicity. Eur J Med Chem 2010; 45:4797-806. [PMID: 20813437 DOI: 10.1016/j.ejmech.2010.07.046] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2009] [Revised: 07/01/2010] [Accepted: 07/27/2010] [Indexed: 10/19/2022]
Abstract
The new heterobimetallic Ni(II)-Sn(2)(IV) (1), Cu(II)-Sn(2)(IV) (2) and Zn(II)-Sn(2)(IV) (3) complexes, containing D-glucosamine, 1,8-diamino-3,6-diazaoctane and imidazole were isolated and characterized by spectral and analytical methods. The proposed geometry of Ni(II) and Cu(II) in 1 and 2 was square pyramidal, Zn(II) in 3 exhibited tetrahedral while Sn(IV) exhibits hexacoordinate environment, respectively. The X-ray powder diffraction (XRPD) confirmed the amorphous nature of all the complexes. The interaction studies of 2 and 3 with CT DNA were carried out by various biophysical techniques to show the mode of binding. The interaction of 2 and 3 with nucleotides viz 5'-GMP and 5'-TMP, respectively were further confirmed by (1)H, (31)P and (119)Sn NMR spectroscopy. The complex 2 exhibited effective cleavage activity with pBR322 DNA. Furthermore, the cytotoxicity of 2 was examined on a panel of human tumor cell lines of different histological origins and showed good activity against Colo205 and A2780 (GI50 < 10 μg/ml).
Collapse
Affiliation(s)
- Sartaj Tabassum
- Department of Chemistry, Aligarh Muslim University, Aligarh, UP 202002, India.
| | | | | | | | | |
Collapse
|
29
|
García-Alvarez I, Garrido L, Doncel-Pérez E, Nieto-Sampedro M, Fernández-Mayoralas A. Detection of metabolite changes in C6 glioma cells cultured with antimitotic oleyl glycoside by 1H MAS NMR. J Med Chem 2010; 52:1263-7. [PMID: 19199478 DOI: 10.1021/jm8012807] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The synthetic glycoside, oleyl N-acetyl-alpha-D-glucosaminide (1), was previously shown to exhibit antimitotic activity on rat (C6) and human (U-373) glioma lines. To obtain information about its mechanism of action, metabolite changes in C6 glioma cells were analyzed after treatment with 1 using high-resolution magic angle spinning (1)H NMR. Compound 1 caused either a decrease or an increase in the intensity of the signal assigned to coenzyme A (CoA) metabolites depending on the concentration used. The data obtained from the (1)H NMR spectra of cells cultured with 1, combined with those obtained after treatment with oleic acid (an inhibitor of acetyl-CoA carboxylase) and phenyl butyrate (a known antineoplastic agent), suggest that 1 may be altering the metabolism of fatty acids and induce apoptosis of C6 glioma cells. These results point to NMR spectroscopy as an efficient technique for monitoring the response of the cells to therapeutic agents.
Collapse
|
30
|
Gregoli L, Danieli C, Barra AL, Neugebauer P, Pellegrino G, Poneti G, Sessoli R, Cornia A. Magnetostructural Correlations in Tetrairon(III) Single-Molecule Magnets. Chemistry 2009; 15:6456-67. [DOI: 10.1002/chem.200900483] [Citation(s) in RCA: 86] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
31
|
López Donaire M, Parra-Cáceres J, Vázquez-Lasa B, García-Álvarez I, Fernández-Mayoralas A, López-Bravo A, San Román J. Polymeric drugs based on bioactive glycosides for the treatment of brain tumours. Biomaterials 2009; 30:1613-26. [DOI: 10.1016/j.biomaterials.2008.12.006] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2008] [Accepted: 12/01/2008] [Indexed: 02/05/2023]
|
32
|
Yang Y, Yu B. N-Dimethylphosphoryl-protection in the efficient synthesis of glucosamine-containing oligosaccharides with alternate N-acyl substitutions. Tetrahedron Lett 2007. [DOI: 10.1016/j.tetlet.2007.07.108] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|